THE FIRST‐IN‐CLASS ETS INHIBITOR TK‐216 INTERFERES WITH ETS TRANSCRIPTION FACTORS AND SYNERGIZE WITH LENALIDOMIDE IN LYMPHOMA. - Spriano, F.; Chung, E.; Napoli, S.; Tarantelli, C.; Gaudio, E.; Cascione, L.; Cavalli, A.; Rinaldi, A.; Kwee, I.; Ye, H.; Rossi, D.; Zucca, E.; et al. (Hematological oncology, 2019)